Whitehawk Therapeutics (WHWK) Return on Invested Capital (2021 - 2022)
Whitehawk Therapeutics' (WHWK) quarterly Return on Invested Capital came in at 2.35% in Q3 2022, down 229.0% year-on-year from 1.82% in Q3 2021, and up 51.46% on a QoQ basis from 4.84% in Q2 2022.
Whitehawk Therapeutics (WHWK) Return on Invested Capital (2021 - 2022) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Return on Invested Capital data on file, last reported at 2.35% in Q3 2022.
- On a quarterly basis, Return on Invested Capital fell 229.0% year-over-year to 2.35% in Q3 2022; TTM through Sep 2022 was 2.35%, a 229.0% decrease from a year earlier, with the FY2021 full-year figure at 0.15%, changed N/A from the prior year.
- Return on Invested Capital for Q3 2022 stood at 2.35%, up from 4.84% in the prior quarter.
- Over the last five years, Return on Invested Capital for WHWK reached as high as 0.06% in Q3 2021 and fell as low as 4.84% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -2.35% |
| Jun 30, 2022 | -4.84% |
| Mar 31, 2022 | -4.32% |
| Dec 31, 2021 | -0.15% |
| Sep 30, 2021 | -0.06% |